News Article
Mike Thompson to lead Replisaurus
As the company prepares its technology for launch, the new executive will provide leadership and management skills for its commercialisation.
When you want to commercialise a remarkable new metallisation technology, it makes sense to enlist the help of someone with remarkable skill in bringing technology out of the lab and into the fab. Replisaurus Technologies, announced that Mike Thompson, former deputy Chief Technology Officer for STMicroelectronics, has signed on as Chief Operating Officer, and will play a leading role in bringing the company’s innovative metallization process to market.
With 17 years of experience at STMicroelectronics’ Crolles, France, operation, Thompson has overseen the lab to fab evolution of dozens of new processes and materials at one of the world’s most innovative chipmaking facilities. Thompson’s vote of confidence in Replisaurus and its ElectroChemical Pattern Replication (ECPR) technique, and his track record of making technology transitions simple and risk free for some of the world’s top semiconductor companies, will enable Replisaurus to offer new levels of customer support and partnering ability.
"Talk about right time, right talent," said James Quinn, CEO of Replisaurus. "Mike has a rare level of expertise and experience in this industry, and simply knows how to make things happen. This is a game changer for Replisaurus, and we couldn't be happier about his decision to join our company."
A major element in Thompson’s role as COO will be integration of Replisaurus' ElectroChemical Pattern Replication (ECPR) technology into production robust equipment and process solutions, in preparation for market introduction.
Replisaurus' ECPR process reduces metallisation process complexity and boosts production speed by eliminating many steps from the traditional process flow. Initial target markets include key growth sectors such as integrated passives, copper pillars and 3D integration. ECPR enables improved accuracy and significant cost and time savings, with a fab-friendly, environmentally clean process that doesn't use solvents or strippers.
"There are many promising technologies in the semiconductor world today, but ECPR represents a genuine insight, and has to be at the top of anyone’s list. The Replisaurus technology has legs, it addresses both technical and economic issues in one clean package, and I expect it to be warmly received,” said Thompson. “It's also exciting for me to join a fast moving start up company, where I'll be able to work closely with the talented team that Jim has put in place."
Thompson will be based at the Replisaurus facility in Saint Jeoire, France, where he will manage the development of the fully integrated ECPR equipment line, as well as extension and enhancement of the high-accuracy chip tochip and chip to wafer bonding products developed by S.E.T. Smart Equipment Technology, which was recently acquired by Replisaurus. S.E.T. has proven equipment production capabilities and technology that enables advanced applications like 3D chip integration. Thompson has extensive hands-on experience with these technologies, which are key components in Replisaurus' industrialisation plans.
Thompson also has wide ranging operational and manufacturing experience, particularly in bringing new technologies into high-volume production. Most recently, he was the deputy CTO of STMicroelectronics, with responsibility for CMOS R&D, covering design and process technology and the Crolles 200mm and 300mm operations. Prior to this, Thompson was instrumental in ST’s participation in the CMOS Alliance with IBM in East Fishkill, New York, and he helped establish the Crolles 2 Derivatives Technology Alliance in Crolles.
Replisaurus has strong financial backing, and the company plans to announce additional funding later this year, as it pushes ahead into the next major stage of commercialisation.
With 17 years of experience at STMicroelectronics’ Crolles, France, operation, Thompson has overseen the lab to fab evolution of dozens of new processes and materials at one of the world’s most innovative chipmaking facilities. Thompson’s vote of confidence in Replisaurus and its ElectroChemical Pattern Replication (ECPR) technique, and his track record of making technology transitions simple and risk free for some of the world’s top semiconductor companies, will enable Replisaurus to offer new levels of customer support and partnering ability.
"Talk about right time, right talent," said James Quinn, CEO of Replisaurus. "Mike has a rare level of expertise and experience in this industry, and simply knows how to make things happen. This is a game changer for Replisaurus, and we couldn't be happier about his decision to join our company."
A major element in Thompson’s role as COO will be integration of Replisaurus' ElectroChemical Pattern Replication (ECPR) technology into production robust equipment and process solutions, in preparation for market introduction.
Replisaurus' ECPR process reduces metallisation process complexity and boosts production speed by eliminating many steps from the traditional process flow. Initial target markets include key growth sectors such as integrated passives, copper pillars and 3D integration. ECPR enables improved accuracy and significant cost and time savings, with a fab-friendly, environmentally clean process that doesn't use solvents or strippers.
"There are many promising technologies in the semiconductor world today, but ECPR represents a genuine insight, and has to be at the top of anyone’s list. The Replisaurus technology has legs, it addresses both technical and economic issues in one clean package, and I expect it to be warmly received,” said Thompson. “It's also exciting for me to join a fast moving start up company, where I'll be able to work closely with the talented team that Jim has put in place."
Thompson will be based at the Replisaurus facility in Saint Jeoire, France, where he will manage the development of the fully integrated ECPR equipment line, as well as extension and enhancement of the high-accuracy chip tochip and chip to wafer bonding products developed by S.E.T. Smart Equipment Technology, which was recently acquired by Replisaurus. S.E.T. has proven equipment production capabilities and technology that enables advanced applications like 3D chip integration. Thompson has extensive hands-on experience with these technologies, which are key components in Replisaurus' industrialisation plans.
Thompson also has wide ranging operational and manufacturing experience, particularly in bringing new technologies into high-volume production. Most recently, he was the deputy CTO of STMicroelectronics, with responsibility for CMOS R&D, covering design and process technology and the Crolles 200mm and 300mm operations. Prior to this, Thompson was instrumental in ST’s participation in the CMOS Alliance with IBM in East Fishkill, New York, and he helped establish the Crolles 2 Derivatives Technology Alliance in Crolles.
Replisaurus has strong financial backing, and the company plans to announce additional funding later this year, as it pushes ahead into the next major stage of commercialisation.
